Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Shanghai Haohai Biological Technology Co., Ltd. Class H ( (HK:6826) ) has issued an update.
Shanghai Haohai Biological Technology Co., Ltd. has announced a final cash dividend of RMB 0.6 per share for the financial year ending December 31, 2024, with the payment date set for July 18, 2025. The dividend will be paid in Hong Kong dollars at an exchange rate of RMB 1 to HKD 1.091715, and the withholding tax rates will vary depending on the residency status of the shareholders, impacting non-resident and resident shareholders differently.
More about Shanghai Haohai Biological Technology Co., Ltd. Class H
Shanghai Haohai Biological Technology Co., Ltd. operates in the biotechnology industry, focusing on the development and production of biological materials and products. The company is known for its innovative solutions in healthcare, particularly in the fields of ophthalmology, orthopedics, and medical aesthetics.
Average Trading Volume: 698,022
Technical Sentiment Signal: Sell
Current Market Cap: HK$11.93B
Learn more about 6826 stock on TipRanks’ Stock Analysis page.